Which of the following drugs for moderate-to-severe psoriasis inhibits both IL-12 and IL23?
Alefacept is anti CD-2 for psoriasis
Efalizumab is anti CD-11a for psoriasis
Ustekinumab targets the p40 subunit of both IL-12 and IL-23 in psoriasis
Abatacept is anti CD-80 and CD-86 for severe RA
Alefacept
Efalizumab
Ustekinumab
Abatacept